Mechanisms and Outcomes of Drug- and Toxicant-Induced Liver Toxicity in Diabetes
- 1 January 2007
- journal article
- review article
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 37 (5) , 413-459
- https://doi.org/10.1080/10408440701215100
Abstract
Increase dincidences of hepatotoxicity have been observed in diabetic patients receiving drug therapies. Neither the mechanisms nor the predisposing factors underlying hepatotoxicity in diabetics are clearly understood. Animal studies designed to examine the mechanisms of diabetes-modulated hepatotoxicity have traditionally focused only on bioactivation/detoxification of drugs and toxicants. It is becoming clear that once injury is initiated, additional events determine the final outcome of liver injury. Foremost among them are two leading mechanisms: first, biochemical mechanisms that lead to progression or regression of injury; and second, whether or not timely and adequate liver tissue repair occurs to mitigate injury and restore liver function. The liver has a remarkable ability to repair and restore its structure and function after physical or chemical-induced damage. The dynamic interaction between biotransformation-based liver injury and compensatory tissue repair plays a pivotal role in determining the ultimate outcome of hepatotoxicity initiated by drugs or toxicants. In this review, mechanisms underlying altered hepatotoxicity in diabetes with emphasis on both altered bioactivation and liver tissue repair are discussed. Animal models of both marked sensitivity (diabetic rats) and equally marked protection (diabetic mice) from drug-induced hepatotoxicity are described. These examples represent a remarkable species difference. Availability of the rodent diabetic models offers a unique opportunity to uncover mechanisms of clinical interest in averting human diabetic sensitivity to drug-induced hepatotoxicities. While the rat diabetic models appear to be suitable, the diabetic mouse models might not be suitable in preclinical testing for potential hepatotoxic effects of drugs or toxicants, because regardless of type 1 or type2 diabetes, mice are resistant to acute drug-or toxicant-induced toxicities.Keywords
This publication has 372 references indexed in Scilit:
- Diabetes, oxidative stress, and antioxidants: A reviewJournal of Biochemical and Molecular Toxicology, 2003
- Exogenously Administered HGF Activator Augments Liver Regeneration through the Production of Biologically Active HGFBiochemical and Biophysical Research Communications, 2002
- Constitutive and Inducible Expression of Hepatic CYP2E1 in Leptin-deficient ob/ob MiceBiochemical and Biophysical Research Communications, 2000
- Altered Expression of HepaticCYP2E1andCYP4Ain Obese, Diabeticob/obMice, andfa/faZucker RatsBiochemical and Biophysical Research Communications, 1999
- Elevated Glucose Concentrations Inhibit DNA Synthesis and Expression of c-myc in Cultured HepatocytesBiochemical and Biophysical Research Communications, 1994
- Unaltered Drug Metabolizing Enzyme Systems in Type II Diabetes Mellitus Before and During Glyburide TherapyThe Journal of Clinical Pharmacology, 1990
- Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failureJournal of Hepatology, 1990
- Generation of alloxan free radicals in chemical and biological systems: Implication in the diabetogenic action of alloxanBiochemical and Biophysical Research Communications, 1989
- Expression of hepatic microsomal cholesterol 7α-hydroxylase activity in lean and obese Zucker ratsBiochemical and Biophysical Research Communications, 1988
- Insulin receptor autophosphorylation and kinase activity in streptozotocin diabetic rats. Effect of a short fastBiochemical and Biophysical Research Communications, 1986